Earth Science Tech Reports Fiscal 2026 Growth as It Integrates Telemedicine, Pharmacy and Fulfillment

Earth Science Tech Inc. reported fiscal 2026 results with revenue up 8% to $35.7 million and net income up 11% to $3.6 million, driven by its vertically integrated healthcare platform connecting telemedicine, pharmacy and direct-to-patient fulfillment.

Bay Area Metrowire Staff
Healthcare
Earth Science Tech Reports Fiscal 2026 Growth as It Integrates Telemedicine, Pharmacy and Fulfillment

Earth Science Tech Inc. (OTC: ETST) recently announced its fiscal year 2026 results for the year ended March 31, 2026, showing growth across key financial metrics as the company continues to execute its diversified holdings strategy spanning healthcare, pharmaceuticals, telemedicine, real estate and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million, according to the company's press release.

CEO Giorgio R. Saumat attributed the results to ETST's efforts to fully integrate the patient experience across telemedicine, pharmacy and fulfillment. The company's core value proposition lies in the seamless integration of patient care from consultation to final product delivery, achieved through the synergy of its specialized subsidiaries. This end-to-end platform differentiates Earth Science Tech in the health and wellness sector, where patients increasingly seek convenient, coordinated care.

Earth Science Tech operates as a diversified holding company focused on health and wellness. Its principal strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. By connecting these elements, ETST aims to create a comprehensive ecosystem that improves patient outcomes and operational efficiency.

The fiscal 2026 results demonstrate the company's ability to grow revenue and profitability while expanding its asset base. The 27% increase in total assets to $9 million suggests strategic investments in infrastructure and capabilities to support future growth. As healthcare continues to shift toward integrated, patient-centric models, Earth Science Tech's approach could position it well to capture market share.

For more details, the full article is available at https://nnw.fm/u6mhk. To learn more about Earth Science Tech, visit www.EarthScienceTech.com.

Blockchain Registration

QR Code for Blockchain Registration